Summary

The hospital acquired infection control market is projected to reach USD 31.3 billion by 2026 from USD 29.1 billion in 2021, at a CAGR of 1.5% during the forecast period. The growth of the hospital acquired infection control market can largely be attributed to factors such as the high incidence of hospital-acquired infections, the increasing number of surgical procedures, the growing geriatric population and the increasing incidence of chronic diseases, technological advancements in sterilization equipment, and the growing awareness of environmental & personal hygiene due to COVID-19. The increasing use of E-beam sterilization, reintroduction of ethylene oxide sterilization, and the growing healthcare industry and outsourcing of operation to emerging countries are expected to offer high-growth opportunities for market players during the forecast period.
Currently, with the surge in COVID-19 cases, there is an increasing focus on personal hygiene along with the increasing production of medical nonwovens and single-use products such as face masks and gloves. This is further expected to drive the growth of the hospital acquired infection control market in the coming years. On the other hand, concerns regarding the safety of reprocessed instruments are expected to limit market growth to some extent in the coming years. This, along with factors such as the high cost of endoscope reprocessing and limited reimbursement in developing countries and end-user noncompliance with sterilization standards, is expected to restrain the growth of this market.

The sterilization segment is expected to grow at the highest CAGR during the forecast period
Based on the products and services used in the control of HAIs, the hospital acquired infection control market is segmented into sterilization, disinfectors, endoscope reprocessing products, disinfectants, protective barriers, and other infection control products. The sterilization segment is expected to grow at the highest CAGR during the forecast period. This is attributed to the growing incidence of chronic diseases and pandemics (such as COVID-19), the increasing need to reduce surgical-site infections (SSIs), and the growing number of surgeries performed worldwide. Increasing initiatives and regulatory actions taken by governments in various countries to fortify hospitals with essential infection control standards to prevent the spread of HAIs are also expected to support market growth.
The hospitals & ICUs segment is expected to account for the largest share of the hospital acquired infection control market
Based on end user, the hospital acquired infection control market has been segmented into hospitals & intensive care units (ICUs), ambulatory surgical and diagnostic centers, nursing homes and maternity centers, and other end users (dental clinics, trauma centers, and clinical laboratories). The hospitals & ICUs segment accounted for the largest share of the hospital acquired infection control market in 2020. Growth in this market is majorly attributed to the rising prevalence of HAIs, increasing adoption of single-use medical devices, and rising number of surgical procedures worldwide.
Asia Pacific is expected to account for the highest CAGR for players operating in the hospital acquired infection control market
The Asia Pacific hospital acquired infection control market is expected to grow at the highest CAGR from 2021 to 2026. Most of the growth in the hospital acquired infection control market is expected from the emerging countries across the Asia Pacific. The rising number of surgical procedures conducted annually, favorable government regulations, the large patient population, and the rising incidence of COVID-19 are expected to drive the growth of the APAC market during the forecast period.

Break of primary participants was as mentioned below:
• By Company Type – Tier 1–35%, Tier 2–45%, and Tier 3–20%
• By Designation – C-level–35%, Director-level–25%, Others–40%
• By Region – North America–45%, Europe–30%, Asia Pacific–20%, Latin America- 3%, Middle East and Africa–2%

Key players in the Hospital Acquired Infection Control market

The key players operating in the hospital acquired infection control market include STERIS plc (US), Sotera Health Company (US), Getinge AB (Sweden), Advanced Sterilization Products (ASP) (US), Ecolab Inc. (US), 3M Company (US), MATACHANA GROUP (Spain), MMM Group (Germany), Belimed AG (Switzerland), Reckitt Benckiser (UK), Metrex Research LLC (UK), Miele Group (Germany), Pal International (UK), MELAG Medizintechnik GmbH & Co. KG (Germany), Contec, Inc. (US), MEDALKAN (Greece), Systec GmbH (Germany), C.B.M. S.r.l. Medical Equipment (Italy), Continental Equipment Company (US), and BGS Beta-Gamma-Service GmbH & Co. KG (Germany).
Research Coverage:
The report analyzes the hospital acquired infection control market and aims at estimating the market size and future growth potential of this market based on various segments such as products and services, end user, and region. The report also includes a product portfolio matrix of various hospital acquired infection services available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product & service offerings, and key market strategies.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:
• Market Penetration: Comprehensive information on product portfolios offered by the top players in the global hospital acquired infection control market. The report analyzes this market by products and services, and end user
• Service Enhancement/Innovation: Detailed insights on upcoming trends and service launches in the global hospital acquired infection control market
• Market Development: Comprehensive information on the lucrative emerging markets by products and services, and end user
• Market Diversification: Exhaustive information about new services or service enhancements, growing geographies, recent developments, and investments in the global hospital acquired infection control market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, service offerings, competitive leadership mapping, and capabilities of leading players in the global hospital acquired infection control market.

ページTOPに戻る

Table of Contents

1 INTRODUCTION 31
1.1 OBJECTIVES OF THE STUDY 31
1.2 MARKET DEFINITION & SCOPE 31
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 32
1.2.2 MARKET SEGMENTATION 32
FIGURE 1 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET SEGMENTATION 32
1.2.3 YEARS CONSIDERED FOR THE STUDY 33
1.3 CURRENCY 33
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 33
1.4 STAKEHOLDERS 34
2 RESEARCH METHODOLOGY 35
2.1 RESEARCH APPROACH 35
2.2 RESEARCH METHODOLOGY DESIGN 35
FIGURE 2 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET: RESEARCH DESIGN 35
2.2.1 SECONDARY RESEARCH 36
2.2.1.1 Key data from secondary sources 37
2.2.2 PRIMARY DATA 38
FIGURE 3 PRIMARY SOURCES 38
2.2.2.1 Key data from primary sources 39
2.2.2.2 Insights from primary experts 39
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 40
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 40
2.3 MARKET SIZE ESTIMATION: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET 41
FIGURE 6 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 41
FIGURE 7 REVENUE SHARE ANALYSIS ILLUSTRATION 42
FIGURE 8 TOP-DOWN APPROACH 43
FIGURE 9 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE HOSPITAL-ACQUIRED INFECTION CONTROL MARKET (2021–2026) 44
FIGURE 10 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 45
2.4 MARKET BREAKDOWN & DATA TRIANGULATION 46
FIGURE 11 DATA TRIANGULATION METHODOLOGY 46
2.5 MARKET SHARE ESTIMATION 47
2.6 ASSUMPTIONS FOR THE STUDY 47
2.7 LIMITATIONS 47
2.7.1 METHODOLOGY-RELATED LIMITATIONS 47
2.8 RISK ASSESSMENT 48
TABLE 2 RISK ASSESSMENT: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET 48
3 EXECUTIVE SUMMARY 49
FIGURE 12 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2021 VS. 2026 (USD MILLION) 50
FIGURE 13 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANTS,
BY TYPE, 2021 VS. 2026 (USD MILLION) 50
FIGURE 14 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANTS,
BY FORMULATION, 2021 VS. 2026 (USD MILLION) 51
FIGURE 15 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER,
2021 VS. 2026 (USD MILLION) 52
FIGURE 16 GEOGRAPHIC ANALYSIS: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET 53
4 PREMIUM INSIGHTS 55
4.1 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET OVERVIEW 55
FIGURE 17 GROWING INCIDENCE OF HAIS AND INCREASING NUMBER OF SURGICAL PROCEDURES TO DRIVE MARKET GROWTH 55
4.2 ASIA PACIFIC: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER AND COUNTRY 56
FIGURE 18 HOSPITALS & ICUS SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC HOSPITAL-ACQUIRED INFECTION CONTROL MARKET IN 2020 56
4.3 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 57
FIGURE 19 CHINA TO REGISTER THE HIGHEST REVENUE GROWTH DURING THE FORECAST PERIOD 57
4.4 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY REGION (2019–2026) 58
FIGURE 20 NORTH AMERICA WILL CONTINUE TO DOMINATE THE HOSPITAL-ACQUIRED INFECTION CONTROL MARKET DURING THE FORECAST PERIOD 58
4.5 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET: DEVELOPED VS. DEVELOPING MARKETS 59
FIGURE 21 DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH RATE DURING
THE FORECAST PERIOD 59
5 MARKET OVERVIEW 60
5.1 INTRODUCTION 60
5.2 MARKET DYNAMICS 60
TABLE 3 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET: IMPACT ANALYSIS 60
5.2.1 MARKET DRIVERS 61
5.2.1.1 High incidence of hospital-acquired infections (HAIs) 61
5.2.1.2 Increasing number of surgical procedures 63
TABLE 4 US: PERCENTAGE INCREASE IN THE NUMBER OF SURGERIES PERFORMED 63
5.2.1.3 Growing geriatric population and the increasing incidence of chronic diseases 64
5.2.1.4 Technological advancements in sterilization equipment 65
5.2.1.5 Growing awareness of environmental & personal hygiene due to COVID-19 66
5.2.2 MARKET RESTRAINTS 67
5.2.2.1 Concerns regarding the safety of reprocessed instruments 67
5.2.2.2 Adverse effects of chemical disinfectants 67
5.2.2.3 High cost of endoscopy reprocessing and limited reimbursement in developing countries 68
5.2.3 MARKET OPPORTUNITIES 68
5.2.3.1 Reintroduction of ethylene oxide sterilization as a disinfectant in healthcare settings 68
5.2.3.2 Rising adoption of single-use medical nonwovens and devices 69
5.2.3.3 Growing healthcare industry and outsourcing of operations to emerging countries 69
FIGURE 22 INDIA: HEALTHCARE SECTOR GROWTH TREND (USD BILLION) 70
FIGURE 23 INDIA: NUMBER OF HOSPITALIZATIONS DUE TO VARIOUS DISEASES 70
5.2.4 MARKET CHALLENGES 71
5.2.4.1 Complications associated with hospital-acquired infection control procedures 71
5.2.4.2 End-user noncompliance with sterilization standards 71
TABLE 5 US: DECREASING COMPLIANCE AMONG END USERS 72
5.2.4.3 Development of alternative technologies for surface disinfection 72
6 INDUSTRY INSIGHTS 73
6.1 INTRODUCTION 73
6.2 INDUSTRY TRENDS 73
6.2.1 INCREASING ADOPTION OF STERILIZATION USING NO2 73
6.2.2 ROBOTICS UTILIZATION FOR DISINFECTION 74
6.2.3 GROWING POPULARITY OF SINGLE-USE PRODUCTS 75
6.2.4 LAYERING/BUNDLING IN INFECTION PREVENTION 76
6.3 REGULATORY ANALYSIS 76
6.3.1 REGULATORY JURISDICTION 76
TABLE 6 FDA- AND EPA-REGISTERED PRODUCT CATEGORIES 77
6.3.2 BY REGION 77
6.3.2.1 North America 77
6.3.2.1.1 US 77
FIGURE 24 PREMARKET NOTIFICATION: 510(K) APPROVAL FOR REPROCESSED MEDICAL DEVICES 78
6.3.2.1.2 Canada 79
TABLE 7 SPAULDING’S CLASSIFICATION OF MEDICAL EQUIPMENT/DEVICES AND REQUIRED LEVEL OF PROCESSING/REPROCESSING 80
6.3.2.2 Europe 81
TABLE 8 STERILIZATION STANDARDS IN THE EUROPEAN UNION 81
FIGURE 25 CE MARKING FOR REPROCESSED MEDICAL DEVICES 82
6.3.2.3 Asia Pacific 82
6.3.2.3.1 Japan 82
TABLE 9 SOME GUIDELINES FOLLOWED UNDER ISO IN JAPAN 83
TABLE 10 SPECIFICATIONS OF BIS RECOMMENDED FOR USE IN STERILIZATION PROCESSES 83
6.3.2.3.2 Australia 84
6.3.2.4 Latin America 84
6.3.3 ENFORCEMENT POLICY FOR STERILIZERS AND DISINFECTANT DEVICES DURING COVID-19 84
6.3.3.1 Sterilizers 84
TABLE 11 CLASSIFICATION REGULATIONS FOR STERILIZERS 85
6.3.3.2 Disinfectant devices 85
TABLE 12 CLASSIFICATION REGULATION FOR DISINFECTANT DEVICES 85
6.4 TECHNOLOGY ANALYSIS 86
6.4.1 KEY TECHNOLOGIES 86
6.4.2 COMPLEMENTARY TECHNOLOGIES 87
6.4.3 ADJACENT TECHNOLOGIES 87
6.5 PORTER’S FIVE FORCES ANALYSIS 88
TABLE 13 PORTER’S FIVE FORCES ANALYSIS (2020): HOSPITAL-ACQUIRED INFECTION CONTROL MARKET 88
6.5.1 THREAT FROM NEW ENTRANTS 88
6.5.2 THREAT FROM SUBSTITUTES 89
6.5.3 BARGAINING POWER OF SUPPLIERS 89
6.5.4 BARGAINING POWER OF BUYERS 89
6.5.5 INTENSITY OF COMPETITIVE RIVALRY 89
6.6 ECOSYSTEM ANALYSIS 90
FIGURE 26 INFECTION CONTROL MARKET: ECOSYSTEM ANALYSIS 90
6.7 VALUE CHAIN ANALYSIS 91
FIGURE 27 INFECTION CONTROL MARKET: VALUE CHAIN ANALYSIS 91
6.8 TRADE DATA 92
6.8.1 EXPORT DATA (USD) 92
6.8.2 IMPORT DATA (USD) 92
6.9 PATENT ANALYSIS 93
6.9.1 PATENT PUBLICATION TRENDS FOR HOSPITAL-ACQUIRED INFECTION CONTROL 93
FIGURE 28 PATENT PUBLICATION TRENDS (JANUARY 2011–JULY 2021) 93
6.9.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 93
FIGURE 29 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HOSPITAL-ACQUIRED INFECTION CONTROL PATENTS (JANUARY 2011–JULY 2021) 94
FIGURE 30 TOP APPLICANT COUNTRIES/REGIONS FOR HOSPITAL-ACQUIRED INFECTION CONTROL PATENTS (JANUARY 2011–JULY 2021) 95
TABLE 14 LIST OF FEW PATENTS IN THE HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, 2020–2021 95
6.10 IMPACT OF COVID-19 ON THE HOSPITAL-ACQUIRED INFECTION CONTROL MARKET 96

7 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET,
BY PRODUCT & SERVICE 98
7.1 INTRODUCTION 99
TABLE 15 COMMONLY USED INFECTION CONTROL CHEMICALS 99
TABLE 16 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 101
7.2 PROTECTIVE BARRIERS 101
7.2.1 RISING ADOPTION OF NONWOVENS IN SURGICAL INTERVENTIONS TO PROPEL MARKET GROWTH 101
TABLE 17 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR PROTECTIVE BARRIERS, BY COUNTRY, 2019–2026 (USD MILLION) 103
7.3 STERILIZATION 103
TABLE 18 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION,
BY TYPE, 2019–2026 (USD MILLION) 104
TABLE 19 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION,
BY COUNTRY, 2019–2026 (USD MILLION) 104
7.3.1 STERILIZATION EQUIPMENT 105
7.3.1.1 Effectiveness of sterilization equipment in sterilizing heat-sensitive products is expected to boost the market growth 105
TABLE 20 STERILIZATION EQUIPMENT MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 106
7.3.2 STERILIZATION SERVICES 106
7.3.2.1 Increasing prevalence of HAIs and rising surgical interventions to drive market growth 106
TABLE 21 STERILIZATION SERVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 107
7.3.3 STERILIZATION CONSUMABLES & ACCESSORIES 107
7.3.3.1 Low cost and efficacy of sterilization consumables & accessories in monitoring the sterilization process to drive market growth 107
TABLE 22 STERILIZATION CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 109
7.4 DISINFECTANTS 109
TABLE 23 JOINT COMMISSION STANDARDS FOR INFECTION CONTROL AND PREVENTION 110
TABLE 24 COMMON DISINFECTANTS USED IN HEALTHCARE SETTINGS 111
TABLE 25 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANTS,
BY COUNTRY, 2019–2026 (USD MILLION) 112
7.4.1 DISINFECTANTS, BY TYPE 112
TABLE 26 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANTS,
BY TYPE, 2019–2026 (USD MILLION) 113
7.4.1.1 Hand disinfectants 113
7.4.1.1.1 Increasing availability of various hand disinfection options to aid market growth 113
TABLE 27 HAND DISINFECTANTS OFFERED BY KEY MARKET PLAYERS 114
TABLE 28 HAND DISINFECTANTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 115
7.4.1.2 Surface disinfectants 115
7.4.1.2.1 Surface disinfectants limit the transfer of microorganisms that can occur through hand contact between contaminated surfaces and patients or staff 115
TABLE 29 SURFACE DISINFECTANTS OFFERED BY KEY MARKET PLAYERS 116
TABLE 30 SURFACE DISINFECTANTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 117
7.4.1.3 Skin disinfectants 117
7.4.1.3.1 Growing awareness about different HAIs and SSIs to aid market growth 117
TABLE 31 SKIN DISINFECTANTS OFFERED BY KEY MARKET PLAYERS 118
TABLE 32 SKIN DISINFECTANTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 118
7.4.1.4 Instrument disinfectants 119
7.4.1.4.1 Increasing number of surgeries and government initiatives for ensuring cleanliness in healthcare facilities are boosting the instrument disinfectants market 119
TABLE 33 SPAULDING’S CLASSIFICATION OF MEDICAL EQUIPMENT AND THE REQUIRED LEVEL OF REPROCESSING 120
TABLE 34 INSTRUMENT DISINFECTANTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 120
7.4.2 DISINFECTANTS, BY FORMULATION 121
TABLE 35 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANTS,
BY FORMULATION, 2019–2026 (USD MILLION) 121
7.4.2.1 Liquid disinfectants 121
7.4.2.1.1 Liquid formulations are inexpensive and are an effective disinfection solution for porous and nonporous surfaces 121
TABLE 36 LIQUID DISINFECTANTS OFFERED BY KEY MARKET PLAYERS 122
TABLE 37 LIQUID DISINFECTANTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 123
7.4.2.2 Disinfectant wipes 123
7.4.2.2.1 Wipes help eliminate a broad spectrum of bacteria, viruses, and allergens 123
TABLE 38 DISINFECTANT WIPES OFFERED BY KEY MARKET PLAYERS 124
TABLE 39 DISINFECTANT WIPES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 125
7.4.2.3 Disinfectant sprays 125
7.4.2.3.1 Disinfectant sprays are used in fogging techniques for antimicrobial control in hospital rooms and operation theaters 125
TABLE 40 DISINFECTANT SPRAYS OFFERED BY KEY MARKET PLAYERS 126
TABLE 41 DISINFECTANT SPRAYS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 126
7.5 DISINFECTORS 127
7.5.1 GROWING NEED TO REDUCE THE SPREAD OF HAIS IS DRIVING MARKET GROWTH 127
TABLE 42 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTORS,
BY COUNTRY, 2019–2026 (USD MILLION) 128
7.6 ENDOSCOPE REPROCESSING PRODUCTS 128
7.6.1 INCREASING NUMBER OF ENDOSCOPY PROCEDURES CONDUCTED TO DRIVE MARKET GROWTH 128
TABLE 43 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING PRODUCTS, BY COUNTRY, 2019–2026 (USD MILLION) 129
7.7 OTHER INFECTION CONTROL PRODUCTS 130
TABLE 44 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR OTHER INFECTION CONTROL PRODUCTS, BY COUNTRY, 2019–2026 (USD MILLION) 130
8 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER 131
8.1 INTRODUCTION 132
TABLE 45 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER,
2019–2026 (USD MILLION) 132
8.2 IMPACT OF COVID-19 ON THE END USERS IN THE HOSPITAL-ACQUIRED INFECTION CONTROL MARKET 133
8.3 HOSPITALS & INTENSIVE CARE UNITS (ICUS) 133
8.3.1 HIGH PREVALENCE OF HAIS TO DRIVE THE DEMAND FOR DISINFECTION AND STERILIZATION PRODUCTS AMONG HOSPITALS & INTENSIVE CARE UNITS 133
TABLE 46 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR HOSPITALS & INTENSIVE CARE UNITS, BY COUNTRY, 2019–2026 (USD MILLION) 135
8.4 AMBULATORY SURGERY & DIAGNOSTIC CENTERS 136
8.4.1 GROWING NUMBER OF OUTPATIENTS AND AWARENESS OF MINIMALLY INVASIVE SURGERIES IS EXPECTED TO PROPEL MARKET GROWTH 136
TABLE 47 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR AMBULATORY SURGERY & DIAGNOSTIC CENTERS, BY COUNTRY,
2019–2026 (USD MILLION) 137
8.5 NURSING HOMES & MATERNITY CENTERS 138
8.5.1 GROWING NEED TO ENSURE THE SAFETY OF ELDERLY PATIENTS AND RISING SURGICAL PROCEDURES IN WOMEN TO DRIVE THE ADOPTION OF HAI CONTROL PRODUCTS IN THIS END-USER SEGMENT 138
TABLE 48 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR NURSING HOMES & MATERNITY CENTERS, BY COUNTRY, 2019–2026 (USD MILLION) 139
8.6 OTHER END USERS 140
TABLE 49 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR OTHER END USERS, BY COUNTRY, 2019–2026 (USD MILLION) 141
9 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY REGION 142
9.1 INTRODUCTION 143
FIGURE 31 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET: GEOGRAPHIC SNAPSHOT (2020) 143
TABLE 50 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY REGION,
2019–2026 (USD MILLION) 144
9.2 IMPACT OF COVID-19 ON THE HOSPITAL-ACQUIRED INFECTION CONTROL MARKET 144
9.3 NORTH AMERICA 146
TABLE 51 NATIONAL ACUTE CARE HOSPITAL HAI METRICS 147
FIGURE 32 NORTH AMERICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET SNAPSHOT 147
TABLE 52 NORTH AMERICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 148
TABLE 53 NORTH AMERICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET,
BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 148
TABLE 54 NORTH AMERICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION) 148
TABLE 55 NORTH AMERICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019–2026 (USD MILLION) 149
TABLE 56 NORTH AMERICA: DISINFECTANTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 149
TABLE 57 NORTH AMERICA: DISINFECTANTS MARKET, BY FORMULATION,
2019–2026 (USD MILLION) 149
TABLE 58 NORTH AMERICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET,
BY END USER, 2019–2026 (USD MILLION) 150
9.3.1 US 150
9.3.1.1 Increasing prevalence of HAIs, high R&D expenditure, and the presence of well-established pharmaceutical, medical devices, and hospital industries to drive market growth 150
TABLE 59 US: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET,
BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 151
TABLE 60 US: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION) 151
TABLE 61 US: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019–2026 (USD MILLION) 152
TABLE 62 US: DISINFECTANTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 152
TABLE 63 US: DISINFECTANTS MARKET, BY FORMULATION, 2019–2026 (USD MILLION) 152
TABLE 64 US: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019–2026 (USD MILLION) 153
9.3.2 CANADA 153
9.3.2.1 High prevalence of HAIs to increase the adoption of infection control products in the country 153
TABLE 65 CANADA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET,
BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 154
TABLE 66 CANADA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION) 155
TABLE 67 CANADA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019–2026 (USD MILLION) 155
TABLE 68 CANADA: DISINFECTANTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 155
TABLE 69 CANADA: DISINFECTANTS MARKET, BY FORMULATION,
2019–2026 (USD MILLION) 156
TABLE 70 CANADA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019–2026 (USD MILLION) 156
9.4 EUROPE 156
TABLE 71 EUROPE: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 157
TABLE 72 EUROPE: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET,
BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 157
TABLE 73 EUROPE: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION) 158
TABLE 74 EUROPE: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019–2026 (USD MILLION) 158
TABLE 75 EUROPE: DISINFECTANTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 158
TABLE 76 EUROPE: DISINFECTANTS MARKET, BY FORMULATION,
2019–2026 (USD MILLION) 159
TABLE 77 EUROPE: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019–2026 (USD MILLION) 159
9.4.1 GERMANY 159
9.4.1.1 Rising incidence of nosocomial infections and chronic diseases to drive growth in the market in Germany 159
TABLE 78 GERMANY: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET,
BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 160
TABLE 79 GERMANY: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION) 160
TABLE 80 GERMANY: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019–2026 (USD MILLION) 161
TABLE 81 GERMANY: DISINFECTANTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 161
TABLE 82 GERMANY: DISINFECTANTS MARKET, BY FORMULATION,
2019–2026 (USD MILLION) 161
TABLE 83 GERMANY: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET,
BY END USER, 2019–2026 (USD MILLION) 162
9.4.2 FRANCE 162
9.4.2.1 High healthcare spending in the country to favor market growth 162
TABLE 84 FRANCE: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET,
BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 163
TABLE 85 FRANCE: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION) 163
TABLE 86 FRANCE: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019–2026 (USD MILLION) 164
TABLE 87 FRANCE: DISINFECTANTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 164
TABLE 88 FRANCE: DISINFECTANTS MARKET, BY FORMULATION,
2019–2026 (USD MILLION) 164
TABLE 89 FRANCE: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019–2026 (USD MILLION) 165
9.4.3 UK 165
9.4.3.1 Rising number of surgical procedures to drive the market growth in the UK 165
TABLE 90 UK: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET,
BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 166
TABLE 91 UK: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION) 167
TABLE 92 UK: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019–2026 (USD MILLION) 167
TABLE 93 UK: DISINFECTANTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 167
TABLE 94 UK: DISINFECTANTS MARKET, BY FORMULATION, 2019–2026 (USD MILLION) 168
TABLE 95 UK: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019–2026 (USD MILLION) 168
9.4.4 ITALY 168
9.4.4.1 Improving quality and accessibility to medical care and technologies to support market growth 168
TABLE 96 ITALY: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET,
BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 169
TABLE 97 ITALY: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION) 169
TABLE 98 ITALY: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019–2026 (USD MILLION) 170
TABLE 99 ITALY: DISINFECTANTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 170
TABLE 100 ITALY: DISINFECTANTS MARKET, BY FORMULATION,
2019–2026 (USD MILLION) 170
TABLE 101 ITALY: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019–2026 (USD MILLION) 171
9.4.5 SPAIN 171
9.4.5.1 Rising incidence of chronic disorders to drive market growth 171
TABLE 102 SPAIN: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET,
BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 172
TABLE 103 SPAIN: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION) 172
TABLE 104 SPAIN: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019–2026 (USD MILLION) 173
TABLE 105 SPAIN: DISINFECTANTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 173
TABLE 106 SPAIN: DISINFECTANTS MARKET, BY FORMULATION,
2019–2026 (USD MILLION) 173
TABLE 107 SPAIN: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019–2026 (USD MILLION) 174
9.4.6 REST OF EUROPE 174
TABLE 108 ROE: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET,
BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 175
TABLE 109 ROE: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION) 175
TABLE 110 ROE: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019–2026 (USD MILLION) 175
TABLE 111 ROE: DISINFECTANTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 176
TABLE 112 ROE: DISINFECTANTS MARKET, BY FORMULATION,
2019–2026 (USD MILLION) 176
TABLE 113 ROE: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019–2026 (USD MILLION) 176
9.5 ASIA PACIFIC 177
FIGURE 33 ASIA PACIFIC: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET SNAPSHOT 178
TABLE 114 ASIA PACIFIC: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 179
TABLE 115 ASIA PACIFIC: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET,
BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 179
TABLE 116 ASIA PACIFIC: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION) 179
TABLE 117 ASIA PACIFIC: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019–2026 (USD MILLION) 180
TABLE 118 ASIA PACIFIC: DISINFECTANTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 180
TABLE 119 ASIA PACIFIC: DISINFECTANTS MARKET, BY FORMULATION,
2019–2026 (USD MILLION) 180
TABLE 120 ASIA PACIFIC: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET,
BY END USER, 2019–2026 (USD MILLION) 181
9.5.1 JAPAN 181
9.5.1.1 Rising standard of care due to the increasing healthcare expenditure to support market growth 181
TABLE 121 JAPAN: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET,
BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 182
TABLE 122 JAPAN: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION) 182
TABLE 123 JAPAN: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019–2026 (USD MILLION) 183
TABLE 124 JAPAN: DISINFECTANTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 183
TABLE 125 JAPAN: DISINFECTANTS MARKET, BY FORMULATION,
2019–2026 (USD MILLION) 183
TABLE 126 JAPAN: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019–2026 (USD MILLION) 184
9.5.2 CHINA 184
9.5.2.1 China is the fastest-growing market for hospital-acquired infection control products and services 184
FIGURE 34 CHINA: TOTAL NUMBER OF HOSPITAL BEDS (2009–2019) 185
TABLE 127 CHINA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET,
BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 186
TABLE 128 CHINA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION) 186
TABLE 129 CHINA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019–2026 (USD MILLION) 186
TABLE 130 CHINA: DISINFECTANTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 187
TABLE 131 CHINA: DISINFECTANTS MARKET, BY FORMULATION,
2019–2026 (USD MILLION) 187
TABLE 132 CHINA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019–2026 (USD MILLION) 187
9.5.3 INDIA 188
9.5.3.1 Large patient population to support the growth of the hospital-acquired infection control market in the country 188
TABLE 133 INDIA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET,
BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 189
TABLE 134 INDIA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION) 189
TABLE 135 INDIA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019–2026 (USD MILLION) 189
TABLE 136 INDIA: DISINFECTANTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 190
TABLE 137 INDIA: DISINFECTANTS MARKET, BY FORMULATION,
2019–2026 (USD MILLION) 190
TABLE 138 INDIA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019–2026 (USD MILLION) 190
9.5.4 REST OF ASIA PACIFIC 191
FIGURE 35 NUMBER OF INBOUND VISITORS TO SOUTH KOREA FROM
2000 TO 2020 (IN MILLIONS) 192
TABLE 139 ROAPAC: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET,
BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 192
TABLE 140 ROAPAC: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION) 193
TABLE 141 ROAPAC: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019–2026 (USD MILLION) 193
TABLE 142 ROAPAC: DISINFECTANTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 193
TABLE 143 ROAPAC: DISINFECTANTS MARKET, BY FORMULATION,
2019–2026 (USD MILLION) 194
TABLE 144 ROAPAC: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019–2026 (USD MILLION) 194
9.6 LATIN AMERICA 194
9.6.1 RISING NUMBER OF COSMETIC SURGERIES IN THE REGION TO DRIVE THE ADOPTION OF INFECTION CONTROL PRODUCTS 194
TABLE 145 LATIN AMERICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET,
BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 195
TABLE 146 LATIN AMERICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION) 195
TABLE 147 LATIN AMERICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019–2026 (USD MILLION) 196
TABLE 148 LATIN AMERICA: DISINFECTANTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 196
TABLE 149 LATIN AMERICA: DISINFECTANTS MARKET, BY FORMULATION,
2019–2026 (USD MILLION) 196
TABLE 150 LATIN AMERICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET,
BY END USER, 2019–2026 (USD MILLION) 197
9.7 MIDDLE EAST & AFRICA 197
9.7.1 IMPROVING HEALTHCARE INFRASTRUCTURE AND FOCUS ON SAFETY MEASURES TO DRIVE MARKET GROWTH 197
TABLE 151 MIDDLE EAST & AFRICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION) 198
TABLE 152 MIDDLE EAST & AFRICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR STERILIZATION, BY TYPE, 2019–2026 (USD MILLION) 199
TABLE 153 MIDDLE EAST & AFRICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET FOR DISINFECTANT PRODUCTS, BY TYPE, 2019–2026 (USD MILLION) 199
TABLE 154 MIDDLE EAST & AFRICA: DISINFECTANTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 199
TABLE 155 MIDDLE EAST & AFRICA: DISINFECTANTS MARKET, BY FORMULATION,
2019–2026 (USD MILLION) 200
TABLE 156 MIDDLE EAST & AFRICA: HOSPITAL-ACQUIRED INFECTION CONTROL MARKET, BY END USER, 2019–2026 (USD MILLION) 200

10 COMPETITIVE LANDSCAPE 201
10.1 OVERVIEW 201
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 201
10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN THE HOSPITAL-ACQUIRED INFECTION CONTROL MARKET 202
10.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 203
FIGURE 36 REVENUE ANALYSIS OF KEY PLAYERS IN THE HOSPITAL-ACQUIRED INFECTION CONTROL MARKET 203
10.4 MARKET SHARE ANALYSIS 204
FIGURE 37 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET SHARE, BY KEY PLAYER, 2020 204
TABLE 157 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET: DEGREE OF COMPETITION 205
10.5 COMPETITIVE BENCHMARKING 206
10.5.1 COMPANY PRODUCT/SERVICE FOOTPRINT 206
TABLE 158 COMPANY PRODUCT OFFERING FOOTPRINT (20 COMPANIES) 207
TABLE 159 COMPANY END-USER FOOTPRINT (20 COMPANIES) 208
TABLE 160 COMPANY REGION FOOTPRINT (20 COMPANIES) 209
10.6 COMPETITIVE LEADERSHIP MAPPING 210
10.6.1 STARS 210
10.6.2 EMERGING LEADERS 210
10.6.3 PERVASIVE PLAYERS 210
10.6.4 PARTICIPANTS 210
FIGURE 38 HOSPITAL-ACQUIRED INFECTION CONTROL MARKET: COMPETITIVE LEADERSHIP MAPPING, 2020 211
10.7 COMPETITIVE SCENARIO 212
10.7.1 PRODUCT LAUNCHES & APPROVALS 212
TABLE 161 PRODUCT LAUNCHES & APPROVALS, 2018–2021 212
10.7.2 DEALS 213
TABLE 162 DEALS, 2018–2021 213
10.7.3 OTHER DEVELOPMENTS 214
TABLE 163 OTHER DEVELOPMENTS, 2018–2021 214
11 COMPANY PROFILES 215
11.1 KEY PLAYERS 215
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
11.1.1 STERIS PLC 215
TABLE 164 STERIS PLC: BUSINESS OVERVIEW 215
FIGURE 39 STERIS PLC: COMPANY SNAPSHOT (2021) 216
11.1.2 SOTERA HEALTH COMPANY 223
TABLE 165 SOTERA HEALTH COMPANY: BUSINESS OVERVIEW 223
FIGURE 40 SOTERA HEALTH COMPANY: COMPANY SNAPSHOT (2020) 224
11.1.3 GETINGE AB 227
TABLE 166 GETINGE AB: BUSINESS OVERVIEW 227
FIGURE 41 GETINGE AB: COMPANY SNAPSHOT (2020) 228
11.1.4 ADVANCED STERILIZATION PRODUCTS (ASP) 236
TABLE 167 ADVANCED STERILIZATION PRODUCTS: BUSINESS OVERVIEW 236
FIGURE 42 FORTIVE CORPORATION: COMPANY SNAPSHOT (2020) 237
11.1.5 ECOLAB INC. 240
TABLE 168 ECOLAB INC.: BUSINESS OVERVIEW 240
FIGURE 43 ECOLAB INC.: COMPANY SNAPSHOT (2020) 241
11.1.6 3M COMPANY 250
TABLE 169 3M COMPANY: BUSINESS OVERVIEW 250
FIGURE 44 3M COMPANY: COMPANY SNAPSHOT (2020) 251
11.1.7 MATACHANA GROUP 257
TABLE 170 MATACHANA GROUP: BUSINESS OVERVIEW 257
11.1.8 MMM GROUP 260
TABLE 171 MMM GROUP: BUSINESS OVERVIEW 260
11.1.9 BELIMED AG (A SUBSIDIARY OF METALL ZUG GROUP) 262
TABLE 172 BELIMED AG: BUSINESS OVERVIEW 262
FIGURE 45 METALL ZUG GROUP: COMPANY SNAPSHOT (2020) 263
11.1.10 RECKITT BENCKISER 266
TABLE 173 RECKITT BENCKISER: BUSINESS OVERVIEW 266
FIGURE 46 RECKITT BENCKISER: COMPANY SNAPSHOT (2020) 267
11.1.11 METREX RESEARCH LLC (A SUBSIDIARY OF DANAHER CORPORATION) 269
TABLE 174 METREX RESEARCH: BUSINESS OVERVIEW 269
FIGURE 47 DANAHER CORPORATION: COMPANY SNAPSHOT (2020) 270
11.1.12 MIELE GROUP 273
TABLE 175 MIELE GROUP: BUSINESS OVERVIEW 273
FIGURE 48 MIELE GROUP: COMPANY SNAPSHOT (2020) 274
11.1.13 PAL INTERNATIONAL 280
TABLE 176 PAL INTERNATIONAL: BUSINESS OVERVIEW 280
11.1.14 MELAG MEDIZINTECHNIK GMBH & CO. KG 282
TABLE 177 MELAG MEDIZINTECHNIK GMBH & CO. KG: BUSINESS OVERVIEW 282
11.1.15 CONTEC, INC. 284
TABLE 178 CONTEC, INC.: BUSINESS OVERVIEW 284
11.1.16 MEDALKAN 287
TABLE 179 MEDALKAN: BUSINESS OVERVIEW 287
11.1.17 SYSTEC GMBH 289
TABLE 180 SYSTEC GMBH: BUSINESS OVERVIEW 289
11.1.18 C.B.M. S.R.L. MEDICAL EQUIPMENT 290
TABLE 181 C.B.M. S.R.L. MEDICAL EQUIPMENT: BUSINESS OVERVIEW 290
11.1.19 CONTINENTAL EQUIPMENT COMPANY 291
TABLE 182 CONTINENTAL EQUIPMENT COMPANY: BUSINESS OVERVIEW 291
11.1.20 BETA-GAMMA-SERVICE GMBH & CO. KG 292
TABLE 183 BETA-GAMMA-SERVICE GMBH & CO. KG: BUSINESS OVERVIEW 292
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
11.2 OTHER PLAYERS 293
11.2.1 MIDWEST STERILIZATION CORPORATION 293
11.2.2 BLUE LINE STERILIZATION SERVICES LLC 293
11.2.3 STERIPACK GROUP 294
11.2.4 STERI-TEK 294
11.2.5 STERILIZATION SERVICES 295
12 APPENDIX 296
12.1 INSIGHTS FROM INDUSTRY EXPERTS 296
12.2 DISCUSSION GUIDE 297
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 301
12.4 AVAILABLE CUSTOMIZATIONS 303
12.5 RELATED REPORTS 303
12.6 AUTHOR DETAILS 304